125 related articles for article (PubMed ID: 34729615)
61. Nodular lymphocyte predominant Hodgkin lymphoma and diffuse large B-cell lymphoma: a study of six cases concurrently involving the same site.
Cotta CV; Coleman JF; Li S; Hsi ED
Histopathology; 2011 Dec; 59(6):1194-203. PubMed ID: 22175899
[TBL] [Abstract][Full Text] [Related]
62. Synchronous Microscopic Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma of the Adrenal and Lymphoplasmacytic Lymphoma: De Novo Disease or Transformation?
Moonim MT; Nasir A; Hubbard J; Ketley N; Fields P
Int J Surg Pathol; 2017 Jun; 25(4):326-332. PubMed ID: 27913781
[TBL] [Abstract][Full Text] [Related]
63. Diffuse large B-cell lymphoma and polycythemia vera discovered at the onset - a rare association and its possible importance in lymphoma prognosis.
Popov VM; Dobrea CM; Popescu M; Pleşea IE; Grigorean VT; Sinescu RD; Strâmbu VD
Rom J Morphol Embryol; 2016; 57(1):313-8. PubMed ID: 27151728
[TBL] [Abstract][Full Text] [Related]
64. Diffuse large B-cell lymphoma as a sequela of Stevens-Johnson syndrome associated with an increased Epstein-Barr virus load.
Hirahara K; Kano Y; Ishida T; Shiohara T
Eur J Dermatol; 2012; 22(1):144-5. PubMed ID: 22064249
[No Abstract] [Full Text] [Related]
65. [Diffuse large B-cell lymphoma of the knee occurring 70 years after tuberculous arthritis].
Ueno S; Yamaguchi M; Ogawa S; Saito K; Takemitu T; Nishikawa H; Tawara I; Kobayashi T; Shiku H
Rinsho Ketsueki; 2004 Apr; 45(4):304-7. PubMed ID: 15168446
[TBL] [Abstract][Full Text] [Related]
66. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma.
Park S; Lee J; Ko YH; Han A; Jun HJ; Lee SC; Hwang IG; Park YH; Ahn JS; Jung CW; Kim K; Ahn YC; Kang WK; Park K; Kim WS
Blood; 2007 Aug; 110(3):972-8. PubMed ID: 17400912
[TBL] [Abstract][Full Text] [Related]
67. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
[TBL] [Abstract][Full Text] [Related]
68. Diffuse large B-cell lymphoma variants: an update.
Sukswai N; Lyapichev K; Khoury JD; Medeiros LJ
Pathology; 2020 Jan; 52(1):53-67. PubMed ID: 31735345
[TBL] [Abstract][Full Text] [Related]
69. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
Cohen M; De Matteo E; Narbaitz M; Carreño FA; Preciado MV; Chabay PA
Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474
[TBL] [Abstract][Full Text] [Related]
70. Hypercalcemia at diagnosis of diffuse large B-cell lymphoma is not uncommon and is associated with high-risk features and a short diagnosis-to-treatment interval.
Gauchy AC; Kanagaratnam L; Quinquenel A; Gaillard B; Rodier C; Godet S; Delmer A; Durot E
Hematol Oncol; 2020 Aug; 38(3):326-333. PubMed ID: 32270502
[TBL] [Abstract][Full Text] [Related]
71. Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era.
Morton LM; Kim CJ; Weiss LM; Bhatia K; Cockburn M; Hawes D; Wang SS; Chang C; Altekruse SF; Engels EA; Cozen W
Leuk Lymphoma; 2014 Mar; 55(3):551-7. PubMed ID: 23772639
[TBL] [Abstract][Full Text] [Related]
72. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
[TBL] [Abstract][Full Text] [Related]
73. Epstein-Barr Virus-Positive Diffuse Large B cell Lymphoma in the Experience of a Tertiary Medical Center in Poland.
Ziarkiewicz M; Wołosz D; Dzieciątkowski T; Wilczek E; Dwilewicz-Trojaczek J; Jędrzejczak WW; Gierej B; Ziarkiewicz-Wróblewska B
Arch Immunol Ther Exp (Warsz); 2016 Apr; 64(2):159-69. PubMed ID: 26084760
[TBL] [Abstract][Full Text] [Related]
74. A Rare, Yet Treatable Pancreatic Tumor: Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma.
Xie J; Rinker E; Zaarour M
Am J Case Rep; 2020 Mar; 21():e921269. PubMed ID: 32176677
[TBL] [Abstract][Full Text] [Related]
75. Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Beltran BE; Quiñones P; Morales D; Malaga JM; Chavez JC; Sotomayor EM; Castillo JJ
Hematol Oncol; 2018 Feb; 36(1):93-97. PubMed ID: 28639256
[TBL] [Abstract][Full Text] [Related]
76. pSTAT3 and MYC in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Teoh SH; Khoo JJ; Abdul Salam DSD; Peh SC; Cheah SC
Malays J Pathol; 2019 Dec; 41(3):273-281. PubMed ID: 31901912
[TBL] [Abstract][Full Text] [Related]
77. Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells.
Ohashi A; Kato S; Okamoto A; Inaguma Y; Satou A; Tsuzuki T; Emi N; Okamoto M; Nakamura S
Histopathology; 2017 Jul; 71(1):89-97. PubMed ID: 28231401
[TBL] [Abstract][Full Text] [Related]
78. Diffuse Large B-Cell Lymphoma Arising within Ileal Neobladder: An Expanding Spectrum of Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation.
Lee H; Shin H; Kim NY; Park HS; Park J
Cancer Res Treat; 2019 Oct; 51(4):1666-1670. PubMed ID: 30913860
[TBL] [Abstract][Full Text] [Related]
79. Cardiac Recurrence of Diffuse Large B-cell Lymphoma More Than a Decade After Attaining Complete Remission.
Amari K; Tago M; Katsuki NE; Fukumori N; Yamashita SI
Am J Case Rep; 2018 Sep; 19():1057-1062. PubMed ID: 30177676
[TBL] [Abstract][Full Text] [Related]
80. Fibrin-associated diffuse large B-cell lymphoma with aberrant CD4 expression.
Tariq H; Zahra U
Blood; 2022 Jan; 139(4):635. PubMed ID: 35084471
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
